Phase I study of sorafenib plus ifosfamide in patients with advanced soft tissue and bone sarcoma: A Spanish Group for Research on Sarcomas (GEIS) study.

被引：0
|
作者：
Garcia del Muro, X.
Lopez-Pousa, A.
Martin Broto, J.
Cubedo, R.
Jimenez Colomo, L.
Gallego, O.
Prevencio-Pulla, M.
机构：
[1] Inst Catalan Oncol, Barcelona, Spain
[2] Hosp Santa Creu & Sant Pau, Barcelona, Spain
[3] Hosp Son Dureta, Palma De Mallorca, Spain
[4] Hosp Puerta de Hierro, Madrid, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10024
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Clinical practice guidelines for the diagnosis and treatment of patients with soft tissue sarcoma by the Spanish group for research in sarcomas (GEIS)
    Xavier Garcia del Muro
    Enrique de Alava
    Vicenç Artigas
    Silvia Bague
    Alejandro Braña
    Ricardo Cubedo
    Josefina Cruz
    Nuria Mulet-Margalef
    Jose A. Narvaez
    Oscar Martinez Tirado
    Claudia Valverde
    Ramona Verges
    Joan Viñals
    Javier Martin-Broto
    Cancer Chemotherapy and Pharmacology, 2016, 77 : 133 - 146
  • [22] Clinical practice guidelines for the diagnosis and treatment of patients with soft tissue sarcoma by the Spanish group for research in sarcomas (GEIS)
    Garcia del Muro, Xavier
    de Alava, Enrique
    Artigas, Vicenc
    Bague, Silvia
    Brana, Alejandro
    Cubedo, Ricardo
    Cruz, Josefina
    Mulet-Margalef, Nuria
    Narvaez, Jose A.
    Martinez Tirado, Oscar
    Valverde, Claudia
    Verges, Ramona
    Vinals, Joan
    Martin-Broto, Javier
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 77 (01) : 133 - 146
  • [23] Phase II trial of temozolomide as first-line treatment for patients with advanced gynecological sarcoma: A Spanish Group for Research on Sarcomas (GEIS) and Spanish Ovarian Cancer Research Group (GEICO) study.
    Del Muro, X. Garcia
    Poveda, A.
    Buesa, J. M.
    Trufero, J. Martinez
    De Sande, L. M.
    Calvo, E.
    Escudero, P.
    Pousa, A. Lopez
    Fabregat, X.
    Casado, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 537S - 537S
  • [24] Trabectedin plus radiotherapy on symptomatic advanced sarcoma patients: Results from the SYNERGIAS study - A Spanish group for research in sarcoma (GEIS) phase II study
    Martin-Broto, J.
    Kopeckova, K.
    Azinovic, I.
    Cruz Jurado, J.
    Guzman, L.
    Alvarez, R. M.
    Casado Herraez, A.
    Valverde Morales, C. M.
    Sanchez, A. Redondo
    Teres Lleida, R.
    Alvarez Gonzalez, A.
    Dolado, M. C.
    Doval, A.
    Belinchon, B.
    Merino, J. A.
    Mendez, R.
    Ledesma, P.
    Gutierrez, A.
    Da Silva Moura, D.
    Hindi Muniz, N.
    ANNALS OF ONCOLOGY, 2023, 34 : S1035 - S1036
  • [25] Predictive gene signature for trabectedin efficacy in advanced soft-tissue sarcoma: A Spanish group for research in sarcoma (GEIS) study
    Silva Moura, David
    Cordero Varela, Juan A.
    Alvarez, Ramiro
    Agra Pujol, Carolina
    Izquierdo, Francisco
    Ramos, Rafael
    Ortega, Luis
    Martin-Davila, Francisco
    Hernandez Leon, Nieves
    Romagosa, Cleofe
    Vaz-Salgado, Maria Angeles
    Lavernia, Javier
    Bague, Silvia
    Mayodormo-Aranda, Empar
    Mondaza-Hernandez, Jose Lucinio
    Renshaw-Calderon, Marta
    Hindi, Nadia
    Valverde Morales, Claudia
    Martinez-Trufero, Javier
    Martin Broto, Javier
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [26] Effect of high-dose ifosfamide in advanced soft tissue sarcomas.: A multicentre phase II study of the EORTC Soft Tissue and Bone Sarcoma Group
    Nielsen, OS
    Judson, I
    van Hoesel, Q
    le Cesne, A
    Keizer, HJ
    Blay, JY
    van Oosterom, A
    Radford, JA
    Svancárová, L
    Krzemienlecki, K
    Hermans, C
    van Glabbeke, M
    Oosterhuis, JW
    Verweij, J
    EUROPEAN JOURNAL OF CANCER, 2000, 36 (01) : 61 - 67
  • [27] Nilotinib as co-adjuvant treatment with doxorubicin in sarcomas: Phase I trial results-A Spanish Group for Research on Sarcoma (GEIS) study.
    Martin Broto, Javier
    Redondo, Andres
    Martinez-Trufero, Javier
    Maria Valverde, Claudia
    Angeles Vaz, Maria
    Javier, Medina
    Obrador, Antonia
    Felipe, Irene
    Castelo, Beatriz
    Hidalgo, Paula
    Pajares, Isabel
    Duran, Jose
    Amurrio, Raul
    Alemany, Regina
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [28] CUL4A and ERCC1 genesas predictive factors for trabectedin efficacy in advanced soft tissue sarcomas (STS): A Spanish Group for Sarcoma Research (GEIS) study.
    Broto, Javier Martin
    Fernandez-Serra, Antonio
    Lopez-Pousa, Antonio
    Gutierrez, Antonio
    De Las Penas, Ramon
    Martinez-Trufero, Javier
    Cruz, Josefina
    Alvarez, Rosa Maria
    Cubedo, Ricardo
    Redondo, Andres
    Carrasco, Juan Antonio
    Lopez-Martin, Jose A.
    Sala, Maria Angeles
    Sevilla, Isabel
    Balana, Carmen
    Salgado, Maria Angeles Vaz
    De Juan, Ana
    Poveda, Andres
    Hindi, Nadia
    Lopez-Guerrero, Jose Antonio
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [29] IMMUNOSARC: A collaborative Spanish (GEIS) and Italian (ISG) sarcoma groups phase I/II trial of sunitinib plus nivolumab in advanced soft tissue and bone sarcomas: Results of the phase II-soft-tissue sarcoma cohort
    Martin Broto, J.
    Hindi, N.
    Grignani, G. E.
    Martinez Trufero, J.
    Redondo, A.
    Valverde, C.
    Lopez Pousa, A.
    Stacchiotti, S.
    Palmerini, E.
    de Alava, E.
    Moura, D. S.
    Perez Vega, H.
    Collini, P.
    Otero, I.
    Ledesma, P.
    Marchesi, E.
    D'Ambrosio, L.
    Lopez Martin, J. A.
    ANNALS OF ONCOLOGY, 2019, 30 : 684 - 684
  • [30] Temozolomide in the treatment of gynecological leiomyosarcoma:: A Spanish Group for Research on Sarcomas (GEIS) study.
    Del Muro, XG
    Fra, J
    Trufero, JM
    Sevilla, I
    Escudero, P
    Cruz, J
    Martín, J
    Casado, A
    Arrazubi, V
    Buesa, JM
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 823S - 823S
12345